Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 USD | +28.57% | -.--% | -10.00% |
Business Summary
Number of employees: 3
Sales per Business
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Natural Compounds and Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Sales per region
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15/15/15 |
William Abajian
PSD | President | 66 | 01/16/01 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 12/17/12 |
Anna Gluskin
BRD | Director/Board Member | 68 | 22/12/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 22/12/22 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15/15/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,257,377 | 717,257,377 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-10.00% | 9.52M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- ETBI Stock
- Company Eastgate Biotech Corp.